| Nicotinamide for the treatment of heart failure with preserved ejection fraction M Abdellatif, V Trummer-Herbst, F Koser, S Durand, R Adão, ... Science translational medicine 13 (580), eabd7064, 2021 | 130 | 2021 |
| Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension J Correia-Pinto, T Henriques-Coelho, R Roncon-Albuquerque, ... Basic research in cardiology 104, 535-545, 2009 | 83 | 2009 |
| Restoring heart function and electrical integrity: closing the circuit LM Monteiro, F Vasques-Nóvoa, L Ferreira, P Pinto-do-Ó, DS Nascimento NPJ Regenerative medicine 2 (1), 9, 2017 | 76 | 2017 |
| Cardioprotective effects of early and late aerobic exercise training in experimental pulmonary arterial hypertension D Moreira-Gonçalves, R Ferreira, H Fonseca, AI Padrão, N Moreno, ... Basic research in cardiology 110 (6), 57, 2015 | 56 | 2015 |
| Neonatal apex resection triggers cardiomyocyte proliferation, neovascularization and functional recovery despite local fibrosis V Sampaio-Pinto, SC Rodrigues, TL Laundos, ED Silva, ... Stem cell reports 10 (3), 860-874, 2018 | 38 | 2018 |
| In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan R Ribeiro, JC Macedo, M Costa, V Ustiyan, AV Shindyapina, ... Nature Aging 2 (5), 397-411, 2022 | 29 | 2022 |
| A Western-type diet attenuates pulmonary hypertension with heart failure and cardiac cachexia in rats AP Lourenço, F Vasques-Nóvoa, D Fontoura, C Brs-Silva, ... The Journal of nutrition 141 (11), 1954-1960, 2011 | 27 | 2011 |
| Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload M Pintalhao, P Castro‐Chaves, F Vasques‐Novoa, F Gonçalves, ... European journal of heart failure 19 (2), 218-225, 2017 | 26 | 2017 |
| Myocardial edema: an overlooked mechanism of septic cardiomyopathy? F Vasques-Nóvoa, TL Laundos, A Madureira, N Bettencourt, JPL Nunes, ... Shock 53 (5), 616-619, 2020 | 25 | 2020 |
| MicroRNA-155 amplifies nitric oxide/cGMP signaling and impairs vascular angiotensin II reactivity in septic shock F Vasques-Nóvoa, TL Laundos, RJ Cerqueira, C Quina-Rodrigues, ... Critical Care Medicine 46 (9), e945-e954, 2018 | 25 | 2018 |
| Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension D Fontoura, J Oliveira-Pinto, M Tavares-Silva, S Leite, F Vasques-Nóvoa, ... Revista Portuguesa de Cardiologia 33 (4), 213-222, 2014 | 20 | 2014 |
| Fenofibrate and heart failure outcomes in patients with type 2 diabetes: analysis from ACCORD JP Ferreira, F Vasques-Nóvoa, D Ferrão, F Saraiva, I Falcão-Pires, ... Diabetes Care 45 (7), 1584-1591, 2022 | 16 | 2022 |
| Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes JP Ferreira, A Sharma, F Vasques‐Nóvoa, A Angélico‐Gonçalves, ... European Journal of Heart Failure 24 (10), 1792-1801, 2022 | 15 | 2022 |
| Assessing the influence of perfusion on cardiac microtissue maturation: A heart‐on‐chip platform embedding peristaltic pump capabilities D Cruz‐Moreira, R Visone, F Vasques‐Nóvoa, A S. Barros, ... Biotechnology and Bioengineering 118 (8), 3128-3137, 2021 | 15 | 2021 |
| Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: a post hoc analysis of the FIGHT trial JS Neves, F Vasques‐Nóvoa, M Borges‐Canha, AR Leite, A Sharma, ... Diabetes, Obesity and Metabolism 25 (1), 189-197, 2023 | 14 | 2023 |
| Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension AP Lourenço, F Vasques-Nóvoa, J Oliveira-Pinto, D Fontoura, ... Intensive care medicine 38, 1050-1060, 2012 | 14 | 2012 |
| Myocardial oedema: pathophysiological basis and implications for the failing heart F Vasques‐Nóvoa, A Angélico‐Gonçalves, JMG Alvarenga, J Nobrega, ... ESC heart failure 9 (2), 958-976, 2022 | 13 | 2022 |
| Effect of glucagon‐like peptide‐1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: a meta‐analysis of placebo‐controlled randomized trials AR Leite, A Angélico‐Gonçalves, F Vasques‐Nóvoa, M Borges‐Canha, ... Diabetes, Obesity and Metabolism 24 (8), 1676-1680, 2022 | 10 | 2022 |
| Chronic sildenafil therapy in the ZSF1 obese rat model of metabolic syndrome and heart failure with preserved ejection fraction S Leite, L Moreira-Costa, R Cerqueira, C Sousa-Mendes, ... Journal of Cardiovascular Pharmacology and Therapeutics 26 (6), 690-701, 2021 | 10 | 2021 |
| Mitochondrial reversible changes determine diastolic function adaptations during myocardial (reverse) remodeling D Miranda-Silva, P G. Rodrigues, E Alves, D Rizo, ACRG Fonseca, ... Circulation: Heart Failure 13 (11), e006170, 2020 | 10 | 2020 |
